Department of Health
and Human Services (HHS)
and Human Services (HHS)
July 29, 2020
PAR-18-655 - Exploratory/Developmental Grants Program for Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)
National Cancer Institute (NCI)
The purpose of this Notice is to extend the expiration date of PAR-18-655, “Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed" by one Application Due Date.
Therefore, with the addition/extension by one Application Due Date of February 18, 2021, PAR-18-655 will now expire on February 19, 2021.
The following sections in Part 1. Overview Information, Key Dates, have been changed:
Currently reads:
Application Due Date(s): June 19, 2018; November 19, 2018; June 18, 2019; November 19, 2019; June 18, 2020; November 19, 2020
Corrected to read (in italics):
Application Due Date(s): June 19, 2018; November 19, 2018; June 18, 2019; November 19, 2019; June 18, 2020; November 19, 2020; February 18, 2021.
Currently reads:
Scientific Merit Review: November 2018; March 2019; November 2019; March 2020; November 2020; March 2021
Corrected to read (in italics):
Scientific Merit Review: November 2018; March 2019; November 2019; March 2020; November 2020; March 2021; June 2021
Currently reads:
Advisory Council Review: January 2019; May 2019; January 2020; May 2020; January 2021; May 2021
Corrected to read (in italics):
Advisory Council Review: January 2019; May 2019; January 2020; May 2020; January 2021; May 2021; August 2021
Currently reads:
Earliest Start Date: April 2019; July 2019; April, 2020; July 2020; April 2021; July 2021
Corrected to read (in italics):
Earliest Start Date: April 2019; July 2019; April, 2020; July 2020; April 2021; July 2021; November 2021
Currently reads:
Expiration Date: November 20, 2020
Corrected to read (in italics):
Expiration Date: February 19, 2021
All other aspects of PAR-18-655 remain unchanged.
Tiffany Wallace, Ph.D.
National Cancer Institute (NCI)
Telephone:240-276-5114
Email: [email protected]